User menu

Generation and characterization of non-competitive furin-inhibiting nanobodies

Bibliographic reference Zhu, Jingjing ; Declercq, Jeroen ; Roucourt, Bart ; Ghassabeh, Gholamreza H ; Meulemans, Sandra ; et. al. Generation and characterization of non-competitive furin-inhibiting nanobodies. In: Biochemical Journal, Vol. 448, no.1, p. 73-82 (15/11/2012)
Permanent URL http://hdl.handle.net/2078/137844
  1. TAYLOR N. A., Curbing activation: proprotein convertases in homeostasis and pathology, 10.1096/fj.02-0831rev
  2. Creemers John, W.M., Knock-out mouse models of proprotein convertases: unique functions or redundancy?, 10.2741/3055
  3. Roebroek A, Development, 125, 4863 (1998)
  4. Roebroek Anton J. M., Taylor Neil A., Louagie Els, Pauli Ilse, Smeijers Liesbeth, Snellinx An, Lauwers Annick, Van de Ven Wim J. M., Hartmann Dieter, Creemers John W. M., Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver, 10.1074/jbc.m407152200
  5. De Vos L, Int. J. Oncol., 32, 1073 (2008)
  6. Essalmani Rachid, Susan-Resiga Delia, Chamberland Ann, Abifadel Marianne, Creemers John W., Boileau Catherine, Seidah Nabil G., Prat Annik, In VivoEvidence That Furin from Hepatocytes Inactivates PCSK9, 10.1074/jbc.m110.192104
  7. Louagie E., Taylor N. A., Flamez D., Roebroek A. J. M., Bright N. A., Meulemans S., Quintens R., Herrera P. L., Schuit F., Van de Ven W. J. M., Creemers J. W. M., Role of furin in granular acidification in the endocrine pancreas: Identification of the V-ATPase subunit Ac45 as a candidate substrate, 10.1073/pnas.0800340105
  8. Pesu Marko, Watford Wendy T., Wei Lai, Xu Lili, Fuss Ivan, Strober Warren, Andersson John, Shevach Ethan M., Quezado Martha, Bouladoux Nicolas, Roebroek Anton, Belkaid Yasmine, Creemers John, O’Shea John J., T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance, 10.1038/nature07210
  9. Bassi Daniel E., Mahloogi Haleh, Al-Saleem Luma, Lopez De Cicco Ricardo, Ridge John A., Klein-Szanto Andres J. P., Elevated furin expression in aggressive human head and neck tumors and tumor cell lines, 10.1002/mc.1057
  10. Cheng Min, Watson Peter, Paterson Jean, Seidah Nabil, Chrétien Michel, Shiu Robert P.C., Pro-protein convertase gene expression in human breast cancer, 10.1002/(sici)1097-0215(19970611)71:6<966::aid-ijc10>3.0.co;2-4
  11. Page R, Cell. Oncol., 29, 289 (2007)
  12. Gu M, Infect. Immun., 64, 524 (1996)
  13. Tsuneoka M, J. Biol. Chem., 268, 26461 (1993)
  14. Lea N., Lord J. M., Roberts L. M., Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli 0157:H7 Shiga-like toxin-1, 10.1099/13500872-145-5-999
  15. Young John A.T., Collier R. John, Anthrax Toxin: Receptor Binding, Internalization, Pore Formation, and Translocation, 10.1146/annurev.biochem.75.103004.142728
  16. Abrami Laurence, Fivaz Marc, Decroly Etienne, Seidah Nabil G., Jean François, Thomas Gary, Leppla Stephen H., Buckley J. Thomas, van der Goot F. Gisou, The Pore-forming Toxin Proaerolysin Is Activated by Furin, 10.1074/jbc.273.49.32656
  17. Hallenberger Sabine, Bosch Valerie, Angliker Herbert, Shaw Elliott, Klenk Hans-Dieter, Garten Wolfgang, Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60, 10.1038/360358a0
  18. Kido H, J. Mol. Genet. Med., 3, 167 (2008)
  19. Gonzalez-Reyes L., Ruiz-Arguello M. B., Garcia-Barreno B., Calder L., Lopez J. A., Albar J. P., Skehel J. J., Wiley D. C., Melero J. A., Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion, 10.1073/pnas.151098198
  20. Maisner A, J. Gen. Virol., 81, 441 (2000)
  21. Jean F., Thomas L., Molloy S. S., Liu G., Jarvis M. A., Nelson J. A., Thomas G., A protein-based therapeutic for human cytomegalovirus infection, 10.1073/pnas.050504297
  22. Volchkov V. E., Feldmann H., Volchkova V. A., Klenk H.-D., Processing of the Ebola virus glycoprotein by the proprotein convertase furin, 10.1073/pnas.95.10.5762
  23. Scamuffa Nathalie, Siegfried Geraldine, Bontemps Yannick, Ma Liming, Basak Ajoy, Cherel Ghislaine, Calvo Fabien, Seidah Nabil G., Khatib Abdel-Majid, Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells, 10.1172/jci32040
  24. Sarac M. S., Cameron A., Lindberg I., The Furin Inhibitor Hexa-D-Arginine Blocks the Activation of Pseudomonas aeruginosa Exotoxin A In Vivo, 10.1128/iai.70.12.7136-7139.2002
  25. Sarac M. S., Peinado J. R., Leppla S. H., Lindberg I., Protection against Anthrax Toxemia by Hexa-D-Arginine In Vitro and In Vivo, 10.1128/iai.72.1.602-605.2004
  26. Shiryaev Sergey A., Remacle Albert G., Ratnikov Boris I., Nelson Nicholas A., Savinov Alexei Y., Wei Ge, Bottini Massimo, Rega Michele F., Parent Amelie, Desjardins Roxane, Fugere Martin, Day Robert, Sabet Mojgan, Pellecchia Maurizio, Liddington Robert C., Smith Jeffrey W., Mustelin Tomas, Guiney Donald G., Lebl Michal, Strongin Alex Y., Targeting Host Cell Furin Proprotein Convertases as a Therapeutic Strategy against Bacterial Toxins and Viral Pathogens, 10.1074/jbc.m703847200
  27. Becker Gero L., Sielaff Frank, Than Manuel E., Lindberg Iris, Routhier Sophie, Day Robert, Lu Yinghui, Garten Wolfgang, Steinmetzer Torsten, Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics, 10.1021/jm9012455
  28. Cameron Angus, Appel Jon, Houghten Richard A., Lindberg Iris, Polyarginines Are Potent Furin Inhibitors, 10.1074/jbc.m003848200
  29. Misumi Yoshio, Ohkubo Kumiko, Sohda Miwa, Takami Noboru, Oda Kimimitsu, Ikehara Yukio, Intracellular processing of complement pro-C3 and proalbumin is inhibited by rat α1-protease inhibitor variant (Met352→Arg) in transfected cells, 10.1016/0006-291x(90)91382-3
  30. Van Rompaey L, Biochem. J., 326, 507 (1997)
  31. Henrich Stefan, Lindberg Iris, Bode Wolfram, Than Manuel E., Proprotein Convertase Models based on the Crystal Structures of Furin and Kexin: Explanation of their Specificity, 10.1016/j.jmb.2004.10.050
  32. Coppola Julia M., Hamilton Christin A., Bhojani Mahaveer S., Larsen Martha J., Ross Brian D., Rehemtulla Alnawaz, Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity, 10.1016/j.ab.2007.01.013
  33. Jiao G.-S., Cregar L., Wang J., Millis S. Z., Tang C., O'Malley S., Johnson A. T., Sareth S., Larson J., Thomas G., Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine, 10.1073/pnas.0606555104
  34. Conrath K. E., Lauwereys M., Galleni M., Matagne A., Frere J.-M., Kinne J., Wyns L., Muyldermans S.,  -Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae, 10.1128/aac.45.10.2807-2812.2001
  35. Lauwereys M., Potent enzyme inhibitors derived from dromedary heavy-chain antibodies, 10.1093/emboj/17.13.3512
  36. Nguyen Viet Khong, Hamers Raymond, Wyns Lode, Muyldermans Serge, Camel heavy-chain antibodies: diverse germline VHH and specific mechanisms enlarge the antigen-binding repertoire, 10.1093/emboj/19.5.921
  37. De Genst E., Silence K., Decanniere K., Conrath K., Loris R., Kinne J., Muyldermans S., Wyns L., Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies, 10.1073/pnas.0505379103
  38. Creemers John W.M., Kormelink Paul J.Groot, Roebroek Anton J.M., Nakayama Kazuhisa, Van de Ven Wim J.M., Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4, 10.1016/0014-5793(93)81610-c
  39. Creemers John W. M., Pritchard Lynn E., Gyte Amy, Le Rouzic Philippe, Meulemans Sandra, Wardlaw Sharon L., Zhu Xiaorong, Steiner Donald F., Davies Nicola, Armstrong Duncan, Lawrence Catherine B., Luckman Simon M., Schmitz Catherine A., Davies Rick A., Brennand John C., White Anne, Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83–132: Interaction between AGRP83–132and Melanocortin Receptors Cannot Be Influenced by Syndecan-3, 10.1210/en.2005-1373
  40. Ayoubi Torik A. Y., Meulemans Sandra M. P., Roebroek Anton J. M., Van de Ven Wim J. M., Production of recombinant proteins in Chinese Hamster Ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin, 10.1007/bf00424434
  41. Veugelers M., Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene, 10.1093/hmg/9.9.1321
  42. van de Loo Jan-Willem H. P., Creemers John W. M., Bright Nicholas A., Young Bryan D., Roebroek Anton J. M., Van de Ven Wim J. M., Biosynthesis, Distinct Post-translational Modifications, and Functional Characterization of Lymphoma Proprotein Convertase, 10.1074/jbc.272.43.27116
  43. Anderson E, J. Biol. Chem., 268, 24887 (1993)
  44. Molloy S, EMBO J., 13, 18 (1994)
  45. Benjannet Suzanne, Savaria Diane, Laslop Andrea, Munzer Jon Scott, Chrétien Michel, Marcinkiewicz Mieczyslaw, Seidah Nabil G., α1-Antitrypsin Portland Inhibits Processing of Precursors Mediated by Proprotein Convertases Primarily within the Constitutive Secretory Pathway, 10.1074/jbc.272.42.26210
  46. Fugere M., Appel J., Houghten R. A., Lindberg I., Day R., Short Polybasic Peptide Sequences Are Potent Inhibitors of PC5/6 and PC7: Use of Positional Scanning-Synthetic Peptide Combinatorial Libraries as a Tool for the Optimization of Inhibitory Sequences, 10.1124/mol.106.027946
  47. Roebroek Anton J. M., Taylor Neil A., Louagie Els, Pauli Ilse, Smeijers Liesbeth, Snellinx An, Lauwers Annick, Van de Ven Wim J. M., Hartmann Dieter, Creemers John W. M., Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver, 10.1074/jbc.m407152200
  48. Senzer Neil, Barve Minal, Kuhn Joseph, Melnyk Anton, Beitsch Peter, Lazar Martin, Lifshitz Samuel, Magee Mitchell, Oh Jonathan, Mill Susan W, Bedell Cynthia, Higgs Candice, Kumar Padmasini, Yu Yang, Norvell Fabienne, Phalon Connor, Taquet Nicolas, Rao Donald D, Wang Zhaohui, Jay Chris M, Pappen Beena O, Wallraven Gladice, Brunicardi F Charles, Shanahan David M, Maples Phillip B, Nemunaitis John, Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer, 10.1038/mt.2011.269
  49. Revets Hilde, De Baetselier Patrick, Muyldermans Serge, Nanobodies as novel agents for cancer therapy, 10.1517/14712598.5.1.111
  50. Vincke Cécile, Loris Remy, Saerens Dirk, Martinez-Rodriguez Sergio, Muyldermans Serge, Conrath Katja, General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold, 10.1074/jbc.m806889200
  51. De Groeve K., Deschacht N., De Koninck C., Caveliers V., Lahoutte T., Devoogdt N., Muyldermans S., De Baetselier P., Raes G., Nanobodies as Tools for In Vivo Imaging of Specific Immune Cell Types, 10.2967/jnumed.109.070078
  52. Hmila I., Saerens D., Ben Abderrazek R., Vincke C., Abidi N., Benlasfar Z., Govaert J., El Ayeb M., Bouhaouala-Zahar B., Muyldermans S., A bispecific nanobody to provide full protection against lethal scorpion envenoming, 10.1096/fj.09-148213
  53. Jevševar Simona, Kunstelj Menči, Porekar Vladka Gaberc, PEGylation of therapeutic proteins, 10.1002/biot.200900218
  54. Deffar K, Afr. J. Biotechnol., 8, 2645 (2009)